|
|
|||||||
Case Reports |
A 35-year old woman developed Burkitt's lymphoma and was treated with rituximab and CHOP therapy early during pregnancy. Monitoring of rituximab concentrations and B-cell counts in the child revealed a transient complete B-cell depletion associated with high rituximab cord blood concentrations. B-cell recovery was fast, showing a regular immunophenotype without loss of CD20 antigen, no functional deficits and adequate vaccination IgG titers.
This article has been cited by other articles:
![]() |
M. V. Karamouzis, P. A. Konstantinopoulos, A. G. Papavassiliou, O. Mir, P. Berveiller, G. Pons, and C. A. Hudis Trastuzumab -- Mechanism of Action and Use N. Engl. J. Med., October 18, 2007; 357(16): 1664 - 1666. [Full Text] [PDF] |
||||
![]() |
D. Pereg, G. Koren, and M. Lishner The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy Haematologica, September 1, 2007; 92(9): 1230 - 1237. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |